Abstract
Measuring expression levels of cell surface antigens is important for the diagnosis of diseases such as B-cell chronic lymphocytic leukemia and the monitoring of targeted therapy, particularly antibody-based therapy. In some cases, the number of antigens that the therapeutic antibodies bind on the cell surface may reflect the efficacy of therapy. Thus, quantitating the number of molecules on the surface of cells before, during, and after therapy would provide important information for monitoring antibody-based therapy and potentially can be used to adjust dosing. We describe a quantitative flow cytometry approach to measuring levels of the CD20 surface antigen, the molecular target of rituximab.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stashenko, P., Nadler, L. M., Hardy, R., and Schlossman, S. F. (1980) Characterization of a human b lymphocyte-specific antigen. J. Immunol. 125, 1678–1685.
Andeson, K. C., Bates, M. P., Slaughenhoup, B. L., Pinkus, G. S., Schlossman, S. F., and Nadler, L. M. (1984) Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 63, 1424–1433.
Bubien, J. K., Zhou, L. J., Bell, P. D., Frizzell, R. A., and Tedder, T. F. (1993) Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B-lymphocytes. J. Cell Biol. 121, 1121–1132.
Demidem, A., Lam, T., Alas, S., Hariharan, K., Hanna, N., and Bonavida, B. (1997) Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother. Radiopharm. 12, 177–186.
Shan, D., Ledbetter, J. A., and Press, O. W. (2000) Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells. Cancer Immunol. Immunother. 48, 673–683.
Hofmeister, J. K., Cooney, D., and Coggeshall, K. M. (2000) Clustered CD20 induced apoptosis: src-family of kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis. Blood Cells Mol. Dis. 26, 133–143.
McLaughlin, P. (2001) Rituximab: perspective on single agent experience, and future directions in combinational trials. Crit. Rev. Oncol. Hematol. 40, 3–16.
Schulz, H., Winkler, U., Staak, J. O., and Engert, A. (2000) The monoclonal antibodies Campath-1H and rituximab in the therapy of chronic lymphocytic leukemia. Onkologie 23, 526–532.
Czuczman, M. S., Fallon, A., and Mohr, A. (2002) Rituximab in combination with CHOP or fludarabine in low grade lymphoma. Semin. Oncol. 18, 3135–3143.
Maloney, D. G., Liles, T. M., and Czerwinski, D. K. (1994) Phase I clinical trials using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 84, 2457–2466.
Piro, L. D., White, C. A., Grillo-Lopez, A. J., et al. (1999) Extended rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin’s lymphoma. Ann. Oncol. 10, 655–661.
Coiffer, B., Haioun, C., and Ketterer, N. (1998) Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multi-center phase II study. Blood 92, 1927–1932.
Davis, T. A., Czerwinski, D. K., and Levy, R. (1999) Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression. Clin. Cancer Res. 5, 611–615.
Flynn, J. M. and Byrd, J. C. (2000) Campath-1H monoclonal antibody therapy. Curr. Opin. Oncol. 12, 574–581.
van Der Velden, V. H., te Marvelde, J.G., and Hoogeveen, P. G. et al. (2001) Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells. Blood 97, 3197–3204.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Chan, H.E.H., Jilani, I., Chang, R., Albitar, M. (2007). Quantification of Surface Antigens and Quantitative Flow Cytometry. In: Albitar, M. (eds) Monoclonal Antibodies. Methods in Molecular Biology, vol 378. Humana Press. https://doi.org/10.1007/978-1-59745-323-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-59745-323-3_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-567-5
Online ISBN: 978-1-59745-323-3
eBook Packages: Springer Protocols